Klaus Bæk Simonsen

Title: Innovations of Klaus Bæk Simonsen

Introduction

Klaus Bæk Simonsen is a notable inventor based in Odense M, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that act as PDE9 enzyme inhibitors. With a total of five patents to his name, his work has the potential to impact the treatment of neurodegenerative and psychiatric disorders.

Latest Patents

One of his latest patents is focused on "Substituted imidazo[1,5-a]pyrazines as PDE9 inhibitors." This invention is directed towards compounds that inhibit the PDE9 enzyme. It provides a pharmaceutical composition that includes a therapeutically effective amount of the compound along with a pharmaceutically acceptable carrier. The invention also outlines processes for preparing these compounds and methods for treating subjects suffering from neurodegenerative and psychiatric disorders. Another significant patent involves "PDE9 inhibitors with imidazo triazinone backbone," which shares similar objectives and applications in treating various disorders.

Career Highlights

Klaus has worked with H. Lundbeck A/S, a prominent company in the pharmaceutical industry. His experience in this organization has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Throughout his career, Klaus has collaborated with notable professionals, including Karsten Juhl and Niels Svenstrup. These collaborations have likely enriched his research and development efforts.

Conclusion

Klaus Bæk Simonsen's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work in developing PDE9 inhibitors showcases the potential for advancements in treating neurodegenerative and psychiatric disorders.